| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.27 | 0.04 |